Exact Financial Statements From 2010 to 2024
| EXTX Stock | NOK 5.70 0.10 1.72% |
Check Exact Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Exact Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Exact financial statements analysis is a perfect complement when working with Exact Therapeutics Valuation or Volatility modules.
Exact |
Exact Therapeutics AS Company Current Valuation Analysis
Exact Therapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Exact Therapeutics Current Valuation | 432.68 M |
Most of Exact Therapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Exact Therapeutics AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Exact Therapeutics AS has a Current Valuation of 432.68 M. This is 96.99% lower than that of the Healthcare sector and 90.69% lower than that of the Biotechnology industry. The current valuation for all Norway stocks is 97.4% higher than that of the company.
Exact Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Exact Therapeutics's current stock value. Our valuation model uses many indicators to compare Exact Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Exact Therapeutics competition to find correlations between indicators driving Exact Therapeutics's intrinsic value. More Info.Exact Therapeutics AS is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Exact Therapeutics' earnings, one of the primary drivers of an investment's value.About Exact Therapeutics Financial Statements
Exact Therapeutics investors utilize fundamental indicators, such as revenue or net income, to predict how Exact Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
EXACT Therapeutics AS, a clinical stage biotech company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy . The company was founded in 2012 and is based in Oslo, Norway. EXACT THERAPEUTICS is traded on Oslo Stock Exchange in Norway.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Exact Stock
Exact Therapeutics financial ratios help investors to determine whether Exact Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Exact with respect to the benefits of owning Exact Therapeutics security.